BDRON 250 MG TAB

About

BDRON 250 MG TAB contains Bicalutamide, a non-steroidal antiandrogen. It functions by competitively binding to androgen receptors in target tissues, thereby blocking the effects of endogenous androgens such as testosterone and dihydrotestosterone. This antagonistic action inhibits the growth and proliferation of androgen-sensitive prostate cancer cells. Bicalutamide is a crucial component in the treatment of advanced prostate cancer, often used in combination with luteinizing hormone-releasing hormone (LHRH) agonists or surgical castration to achieve maximal androgen blockade, which is a cornerstone of therapy for this disease.

The medication is well-absorbed orally and possesses a long half-life, which allows for convenient once-daily dosing. Its ability to effectively block androgen signaling pathways helps to slow disease progression, reduce tumor burden, and alleviate symptoms associated with prostate cancer, thereby improving the quality of life for affected patients.

Uses

• Advanced prostate cancer (in combination with LHRH analog or castration).
• Locally advanced prostate cancer (as monotherapy or adjuvant).
• Metastatic prostate cancer.
• Non-metastatic castration-resistant prostate cancer.

Directions For Use

Take orally once daily, with or without food, as prescribed by your doctor. Do not exceed the recommended dose.

Benefits

• Effective in blocking androgen effects.
• Slows progression of prostate cancer.
• Improves quality of life in advanced disease.
• Can be used as monotherapy or in combination.
• Convenient once-daily oral dosing.
• Well-tolerated by many patients.

Side Effects

• Hot flashes
• Breast pain/gynecomastia
• Nausea
• Diarrhea
• Constipation
• Liver enzyme elevation
• Fatigue
• Peripheral edema
• Anemia
• Decreased libido
• Erectile dysfunction
• Rash

Safety Measures

• Alcohol - Avoid excessive alcohol consumption due to potential for increased liver strain and exacerbation of side effects.
• Pregnancy - Contraindicated in women, especially during pregnancy, as it can cause fetal harm. Not indicated for use in women.
• Breastfeeding - Not indicated for use in women, therefore not relevant for breastfeeding.
• Liver - Use with caution in patients with moderate to severe liver impairment; monitor liver function tests regularly.
• Kidney - No dose adjustment is typically required in patients with renal impairment.
• Lung - Rare cases of interstitial lung disease have been reported; monitor for new or worsening respiratory symptoms.

Disclaimer

MedEHub is committed to delivering reliable, expert-reviewd information to help consumers make informed health decisions. However, the content provided on this website is for informational purposes only and is not intended to replace professional medical advice, diagnosis or treatment.

Always consult your doctor for any medical concerns, and discuss your questions about health conditions or medications with a qualified healthcare professional. Do not ignore or delay seeking professional medical advice based on information found on Med E Hub.

Our goal is to complement, not replace, the essential doctor-patient relationship.